D E Jewitt

676 total citations
14 papers, 493 citations indexed

About

D E Jewitt is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, D E Jewitt has authored 14 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pharmacology and 1 paper in Surgery. Recurrent topics in D E Jewitt's work include Cardiac electrophysiology and arrhythmias (4 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). D E Jewitt is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). D E Jewitt collaborates with scholars based in United Kingdom and United States. D E Jewitt's co-authors include Martin T. Rothman, D A Chamberlain, R.G. Shanks, Desmond G. Julian, R. W. F. Campbell, V V Kakkar, David de Bono, J T Willerson, Ulrich Sigwart and Eric J. Topol and has published in prestigious journals such as The Lancet, Circulation and Heart.

In The Last Decade

D E Jewitt

14 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D E Jewitt United Kingdom 10 348 139 110 53 48 14 493
J. Bouthier France 15 446 1.3× 188 1.4× 230 2.1× 26 0.5× 66 1.4× 27 680
Robert Renton United Kingdom 6 259 0.7× 84 0.6× 55 0.5× 121 2.3× 21 0.4× 7 442
H A Cameron United Kingdom 9 172 0.5× 119 0.9× 65 0.6× 42 0.8× 21 0.4× 14 420
Roger D. Blevins United States 12 516 1.5× 146 1.1× 28 0.3× 40 0.8× 182 3.8× 21 879
David R. Lowry United States 12 531 1.5× 242 1.7× 97 0.9× 60 1.1× 41 0.9× 17 671
Olga Gorchakova Germany 9 427 1.2× 268 1.9× 112 1.0× 67 1.3× 21 0.4× 23 561
S. D. Kristensen Denmark 7 242 0.7× 107 0.8× 69 0.6× 64 1.2× 15 0.3× 8 368
Tonny Nielsen Denmark 9 965 2.8× 227 1.6× 133 1.2× 34 0.6× 28 0.6× 12 998
Joanna Sikora Poland 11 380 1.1× 141 1.0× 122 1.1× 24 0.5× 16 0.3× 39 500
G Castrucci Italy 8 347 1.0× 180 1.3× 93 0.8× 414 7.8× 11 0.2× 14 756

Countries citing papers authored by D E Jewitt

Since Specialization
Citations

This map shows the geographic impact of D E Jewitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Jewitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Jewitt more than expected).

Fields of papers citing papers by D E Jewitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Jewitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Jewitt. The network helps show where D E Jewitt may publish in the future.

Co-authorship network of co-authors of D E Jewitt

This figure shows the co-authorship network connecting the top 25 collaborators of D E Jewitt. A scholar is included among the top collaborators of D E Jewitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D E Jewitt. D E Jewitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Topol, Eric J., R Bonan, D E Jewitt, et al.. (1993). Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.. Circulation. 87(5). 1622–1629. 172 indexed citations
2.
3.
4.
Kenny, J, et al.. (1984). Beneficial effects of diltiazem in coronary artery disease.. Heart. 52(1). 53–56. 13 indexed citations
5.
Bergman, Geoffrey, et al.. (1983). Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.. British Journal of Clinical Pharmacology. 15(S1). 73S–77S. 13 indexed citations
6.
Timmis, A D, R J McGonigle, M.J. Weston, et al.. (1982). The influence of hemodialysis fistulas on circulatory dynamics and left ventricular function.. PubMed. 5(2). 101–4. 13 indexed citations
7.
Bergman, Geoffrey, L Atkinson, Kieran Daly, et al.. (1981). PROSTACYCLIN: HAEMODYNAMIC AND METABOLIC EFFECTS IN PATIENTS WITH CORONARY ARTERY DISEASE. The Lancet. 317(8220). 569–572. 77 indexed citations
8.
McGonigle, R J, A D Timmis, John P. Keenan, et al.. (1981). The influence of 1 alpha-hydroxycholecalciferol on left ventricular function in end-stage renal failure.. PubMed. 18. 579–85. 6 indexed citations
9.
Chamberlain, D A, et al.. (1980). ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION. The Lancet. 316(8208-8209). 1324–1327. 108 indexed citations
10.
Jackson, Graham, et al.. (1978). The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man.. British Journal of Clinical Pharmacology. 5(1). 7–11. 8 indexed citations
11.
Jennings, K, et al.. (1978). Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease.. British Journal of Clinical Pharmacology. 5(1). 13–18. 8 indexed citations
12.
Kitson, David H., et al.. (1977). Indirect measurement of sinoatrial conduction time in patients with sinoatrial disease and in controls.. Heart. 39(7). 771–777. 12 indexed citations
13.
Birkhead, John, et al.. (1976). Sustained release procainamide in patients with myocardial infarction.. Heart. 38(1). 77–80. 10 indexed citations
14.
Jewitt, D E, John Birkhead, A Mitchell, & C T Dollery. (1974). Proceedings: Cardiovascular effects of dobutamine, a selective inotropic catecholamine.. PubMed. 36(10). 1034–1034. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Bouthier Breakdown of academic impact, for papers by Robert Renton Breakdown of academic impact, for papers by H A Cameron Breakdown of academic impact, for papers by Roger D. Blevins Breakdown of academic impact, for papers by David R. Lowry Breakdown of academic impact, for papers by Olga Gorchakova Breakdown of academic impact, for papers by S. D. Kristensen Breakdown of academic impact, for papers by Tonny Nielsen Breakdown of academic impact, for papers by Joanna Sikora Breakdown of academic impact, for papers by G Castrucci
Rankless by CCL
2026